Skip to main content
. 2022 Oct 31;13:1029891. doi: 10.3389/fneur.2022.1029891

Table 5.

Studies targeting HMGB1 in epilepsy.

S.N. Study model Treatment Mode of inhibition Observations References
1 Pilocarpine-induced SE mouse model GL Release inhibition Decreases levels of malondialdehyde and glutathione in brain regions (82)
2 Pilocarpine-induced epilepsy mouse model anti-HMGB1 mAb Neutralization Attenuates damage such as increased intracellular space in the hippocampus caused by seizures in epileptic mice (83)
3 Pentylenetetrazol-induced epilepsy zebrafish model GL Release inhibition Anticonvulsant
Inhibits HMGB1/TLR4/NF-κB signaling pathway
(84)
4 Lithium-pilocarpine induced epilepsy mouse model GL Release inhibition Inhibits the translocation of HMGB1 from the nucleus to the cytoplasm
Improves the neuronal damage in the CA1 and CA3 regions of the hippocampus after SE
Protects BBB
(85)